BioLineRx (BLRX) Assets (2010 - 2026)
BioLineRx's Assets came in at $33.48 million for the quarter ended Jun 30, 2026, down 22.6% from $43.27 million a year earlier and down 13.7% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Assets (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx's Assets was $40.91 million, up 5.1% from the prior year.
- Assets carries a five-year compound annual growth rate of -2.9% (years ended Dec 2020 to Dec 2025).
- Going back by year, Assets was $38.91 million in the year ended Dec 31, 2024 (-39.1%), $63.93 million in the year ended Dec 31, 2023 (-16.3%), $76.38 million in the year ended Dec 31, 2022 (-6.2%) and $81.39 million in the year ended Dec 31, 2021 (+72.1%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Assets since the quarter ended Sep 30, 2014.
- Year-over-year, Assets increased in 1 of the last eight quarters, with an average decline of 17.6%.
- The fastest year-over-year change in Assets over five years came in the quarter ended Sep 30, 2021 (growth of 88.8%), and the weakest in the quarter ended Dec 31, 2024 (a decline of 39.1%).
- Business Quant data shows BLRX's Assets at $38.8 million (quarter ended Mar 31, 2026), $40.91 million (quarter ended Dec 31, 2025) and $39.8 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | BioLineRx | 6.34 Bn | 6.35 Bn | 235,000.00 | 33.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.48 Mn |
| Mar 31, 2026 | 38.80 Mn |
| Dec 31, 2025 | 40.91 Mn |
| Sep 30, 2025 | 39.80 Mn |
| Jun 30, 2025 | 43.27 Mn |
| Mar 31, 2025 | 43.51 Mn |
| Dec 31, 2024 | 38.91 Mn |
| Sep 30, 2024 | 52.74 Mn |
| Jun 30, 2024 | 64.60 Mn |
| Mar 31, 2024 | 51.60 Mn |
| Dec 31, 2023 | 63.93 Mn |
| Sep 30, 2023 | 52.86 Mn |
| Jun 30, 2023 | 58.94 Mn |
| Mar 31, 2023 | 68.65 Mn |
| Dec 31, 2022 | 76.38 Mn |
| Sep 30, 2022 | 81.67 Mn |
| Jun 30, 2022 | 67.84 Mn |
| Mar 31, 2022 | 74.77 Mn |
| Dec 31, 2021 | 81.39 Mn |
| Sep 30, 2021 | 86.91 Mn |
API Access
BioLineRx Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();